| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MCDONOUGH GEOFF | Director | C/O GENERATION BIO CO., 301 BINNEY ST, CAMBRIDGE | /s/ Shawna-Gay White, Attorney-in-Fact | 04 Feb 2026 | 0001732701 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Common Stock | Options Exercise | +1,582 | +1.2% | 139,042 | 02 Feb 2026 | Direct | F1 | ||
| transaction | GBIO | Common Stock | Tax liability | $3,102 | -550 | -0.4% | $5.64 | 138,492 | 02 Feb 2026 | Direct | |
| holding | GBIO | Common Stock | 22,646 | 02 Feb 2026 | By 2018 Trust | F2 | |||||
| holding | GBIO | Common Stock | 27,500 | 02 Feb 2026 | By 2020 Trust | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -1,582 | -100% | $0.000000 | 0 | 02 Feb 2026 | Common Stock | 1,582 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
| F2 | The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust. |
| F3 | The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust. |
| F4 | On January 20, 2023, the reporting person was granted 8,437 restricted stock units. Pursuant to the terms of that certain Agreement and Plan of Merger, by and among the Issuer, XOMA Royalty Corporation ("Parent") and Parent's wholly-owned subsidiary, XRA 7 Corp., dated as of December 15, 2025 (the "Merger Agreement"), prior to the effective time of the merger as contemplated by the Merger Agreement, each restricted stock unit of the Issuer that was outstanding and unvested became vested in full on February 2, 2026. |